Literature DB >> 27480868

The RTA3 Gene, Encoding a Putative Lipid Translocase, Influences the Susceptibility of Candida albicans to Fluconazole.

Sarah G Whaley1, Sarah Tsao2, Sandra Weber2, Qing Zhang1, Katherine S Barker1, Martine Raymond3, P David Rogers4.   

Abstract

The RTA3 gene, coding for a member of the Rta1p-like lipid-translocating exporter family, is coordinately upregulated with the ATP-binding cassette transporter genes CDR1 and CDR2 in azole-resistant clinical isolates of Candida albicans that carry activating mutations in the transcription factor Tac1p. We show here that deleting RTA3 in an azole-resistant clinical isolate carrying a Tac1p-activating mutation lowered fluconazole resistance by 2-fold, while overexpressing RTA3 in an azole-susceptible clinical isolate resulted in enhanced fluconazole tolerance associated with trailing growth in a liquid microtiter plate assay. We also demonstrate that an Rta3p-green fluorescent protein (GFP) fusion protein localizes predominantly to the plasma membrane, consistent with a putative function for Rta3p as a lipid translocase.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27480868      PMCID: PMC5038240          DOI: 10.1128/AAC.00732-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  PDR16-mediated azole resistance in Candida albicans.

Authors:  Saloua Saidane; Sandra Weber; Xavier De Deken; Guy St-Germain; Martine Raymond
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

2.  Dissecting the regulatory circuitry of a eukaryotic genome.

Authors:  F C Holstege; E G Jennings; J J Wyrick; T I Lee; C J Hengartner; M R Green; T R Golub; E S Lander; R A Young
Journal:  Cell       Date:  1998-11-25       Impact factor: 41.582

3.  Comprehensive annotation of the transcriptome of the human fungal pathogen Candida albicans using RNA-seq.

Authors:  Vincent M Bruno; Zhong Wang; Sadie L Marjani; Ghia M Euskirchen; Jeffrey Martin; Gavin Sherlock; Michael Snyder
Journal:  Genome Res       Date:  2010-09-01       Impact factor: 9.043

4.  The trailing end point phenotype in antifungal susceptibility testing is pH dependent.

Authors:  K A Marr; T R Rustad; J H Rex; T C White
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.

Authors:  Alix Coste; Vincent Turner; Françoise Ischer; Joachim Morschhäuser; Anja Forche; Anna Selmecki; Judith Berman; Jacques Bille; Dominique Sanglard
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

6.  Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009).

Authors:  Michael A Pfaller; Gary J Moet; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

7.  ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators.

Authors:  S Krishnamurthy; B L Dixit; C M Gupta; S Milewski; R Prasad
Journal:  Yeast       Date:  2002-03-15       Impact factor: 3.239

8.  Cross talk between sphingolipids and glycerophospholipids in the establishment of plasma membrane asymmetry.

Authors:  Akio Kihara; Yasuyuki Igarashi
Journal:  Mol Biol Cell       Date:  2004-09-01       Impact factor: 4.138

9.  Genome-wide expression and location analyses of the Candida albicans Tac1p regulon.

Authors:  Teresa T Liu; Sadri Znaidi; Katherine S Barker; Lijing Xu; Ramin Homayouni; Saloua Saidane; Joachim Morschhäuser; André Nantel; Martine Raymond; P David Rogers
Journal:  Eukaryot Cell       Date:  2007-09-28

10.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

View more
  10 in total

1.  Mediator Tail Module Is Required for Tac1-Activated CDR1 Expression and Azole Resistance in Candida albicans.

Authors:  Zhongle Liu; Lawrence C Myers
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

Review 2.  Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.

Authors:  Andrew T Nishimoto; Cheshta Sharma; P David Rogers
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

3.  Distinct roles of the 7-transmembrane receptor protein Rta3 in regulating the asymmetric distribution of phosphatidylcholine across the plasma membrane and biofilm formation in Candida albicans.

Authors:  Archita Srivastava; Shabnam Sircaik; Farha Husain; Edwina Thomas; Shivani Ror; Sumit Rastogi; Darakshan Alim; Priyanka Bapat; David R Andes; Clarissa J Nobile; Sneh L Panwar
Journal:  Cell Microbiol       Date:  2017-10-04       Impact factor: 3.715

4.  Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.

Authors:  Sarah G Whaley; Qing Zhang; Kelly E Caudle; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

5.  Antibiofilm and Antivirulence Activities of 6-Gingerol and 6-Shogaol Against Candida albicans Due to Hyphal Inhibition.

Authors:  Jin-Hyung Lee; Yong-Guy Kim; Pilju Choi; Jungyeob Ham; Jae Gyu Park; Jintae Lee
Journal:  Front Cell Infect Microbiol       Date:  2018-08-28       Impact factor: 5.293

6.  New diphenylphosphane derivatives of ketoconazole are promising antifungal agents.

Authors:  Rodrigo F M de Almeida; Filipa C Santos; Krzysztof Marycz; Michalina Alicka; Anna Krasowska; Jakub Suchodolski; Jarosław J Panek; Aneta Jezierska; Radosław Starosta
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

Review 7.  Role of lipid transporters in fungal physiology and pathogenicity.

Authors:  Juliana Rizzo; Lyubomir Dimitrov Stanchev; Vanessa K A da Silva; Leonardo Nimrichter; Thomas Günther Pomorski; Marcio L Rodrigues
Journal:  Comput Struct Biotechnol J       Date:  2019-09-04       Impact factor: 7.271

8.  Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans.

Authors:  Eric Delarze; Ludivine Brandt; Emilie Trachsel; Marion Patxot; Claire Pralong; Fabio Maranzano; Murielle Chauvel; Mélanie Legrand; Sadri Znaidi; Marie-Elisabeth Bougnoux; Christophe d'Enfert; Dominique Sanglard
Journal:  Front Microbiol       Date:  2020-11-11       Impact factor: 5.640

9.  Characterization of the Candida glabrata Transcription Factor CgMar1: Role in Azole Susceptibility.

Authors:  Pedro Pais; Mónica Galocha; Raquel Califórnia; Romeu Viana; Mihaela Ola; Michiyo Okamoto; Hiroji Chibana; Geraldine Butler; Miguel C Teixeira
Journal:  J Fungi (Basel)       Date:  2022-01-07

10.  Genetic and behavioral adaptation of Candida parapsilosis to the microbiome of hospitalized infants revealed by in situ genomics, transcriptomics, and proteomics.

Authors:  Patrick T West; Samantha L Peters; Matthew R Olm; Feiqiao B Yu; Haley Gause; Yue Clare Lou; Brian A Firek; Robyn Baker; Alexander D Johnson; Michael J Morowitz; Robert L Hettich; Jillian F Banfield
Journal:  Microbiome       Date:  2021-06-21       Impact factor: 14.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.